Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Torsten Haferlach

Showing results (131-140 of 596) with videos related to

Pageof 60
Sort By:
Annals of Hematology|February 5, 2005
Conventional cytogenetics of myeloproliferative diseases other than CML contribute valid informationUlrike Bacher, Torsten Haferlach, Wolfgang Kern, et al.
Haematologica|May 25, 2011
Comparison of genetic and clinical aspects in patients with acute myeloid leukemia and myelodysplastic syndromes all with more than 50% of bone marrow erythropoietic cellsUlrike Bacher, Claudia Haferlach, Tamara Alpermann, et al.
Annals of Hematology|March 3, 2010
Mutations of the TET2 and CBL genes: novel molecular markers in myeloid malignanciesUlrike Bacher, Claudia Haferlach, Susanne Schnittger, et al.
Haematologica|April 12, 2003
Membrane-bound heat shock protein 70 (Hsp70) in acute myeloid leukemia: a tumor specific recognition structure for the cytolytic activity of autologous NK cellsMathias Gehrmann, Helga Schmetzer, Günther Eissner, et al.
Haematologica|March 26, 2003
Acute myeloid leukemia with recurring chromosome abnormalities as defined by the WHO-classification: incidence of subgroups, additional genetic abnormalities, FAB subtypes and age distribution in an unselected series of 1,897 patients with acute myeloid leukemiaClaudia Schoch, Susanne Schnittger, Wolfgang Kern, et al.
Blood|October 18, 2002
A new and recurrent activating length mutation in exon 20 of the FLT3 gene in acute myeloid leukemiaKarsten Spiekermann, Ksenia Bagrintseva, Claudia Schoch, et al.
Blood|July 5, 2003
New score predicting for prognosis in PML-RARA+, AML1-ETO+, or CBFBMYH11+ acute myeloid leukemia based on quantification of fusion transcriptsSusanne Schnittger, Martin Weisser, Claudia Schoch, et al.
Cancer Genetics and Cytogenetics|June 18, 2003
Cytogenetics, fluorescence in situ hybridization, and reverse transcriptase polymerase chain reaction are necessary to clarify the various mechanisms leading to an MLL-AF10 fusion in acute myelocytic leukemia with 10;11 rearrangementMirjam Klaus, Susanne Schnittger, Torsten Haferlach, et al.
Seminars in Hematology|March 28, 2012
Controversies and open questions in the definitions and classification of the hypereosinophilic syndromes and eosinophilic leukemiasPeter Valent, Hans-Peter Horny, Bruce S Bochner, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|September 28, 2004
Four-fold staining including CD45 gating improves the sensitivity of multiparameter flow cytometric assessment of minimal residual disease in patients with acute myeloid leukemiaWolfgang Kern, Daniela Voskova, Susanne Schnittger, et al.
Pageof 60

Showing results (131-140 of 596) with videos related to

Sort By:
Pageof 60
Annals of Hematology|February 5, 2005
Conventional cytogenetics of myeloproliferative diseases other than CML contribute valid informationUlrike Bacher, Torsten Haferlach, Wolfgang Kern, et al.
Haematologica|May 25, 2011
Comparison of genetic and clinical aspects in patients with acute myeloid leukemia and myelodysplastic syndromes all with more than 50% of bone marrow erythropoietic cellsUlrike Bacher, Claudia Haferlach, Tamara Alpermann, et al.
Annals of Hematology|March 3, 2010
Mutations of the TET2 and CBL genes: novel molecular markers in myeloid malignanciesUlrike Bacher, Claudia Haferlach, Susanne Schnittger, et al.
Haematologica|April 12, 2003
Membrane-bound heat shock protein 70 (Hsp70) in acute myeloid leukemia: a tumor specific recognition structure for the cytolytic activity of autologous NK cellsMathias Gehrmann, Helga Schmetzer, Günther Eissner, et al.
Haematologica|March 26, 2003
Acute myeloid leukemia with recurring chromosome abnormalities as defined by the WHO-classification: incidence of subgroups, additional genetic abnormalities, FAB subtypes and age distribution in an unselected series of 1,897 patients with acute myeloid leukemiaClaudia Schoch, Susanne Schnittger, Wolfgang Kern, et al.
Blood|October 18, 2002
A new and recurrent activating length mutation in exon 20 of the FLT3 gene in acute myeloid leukemiaKarsten Spiekermann, Ksenia Bagrintseva, Claudia Schoch, et al.
Blood|July 5, 2003
New score predicting for prognosis in PML-RARA+, AML1-ETO+, or CBFBMYH11+ acute myeloid leukemia based on quantification of fusion transcriptsSusanne Schnittger, Martin Weisser, Claudia Schoch, et al.
Cancer Genetics and Cytogenetics|June 18, 2003
Cytogenetics, fluorescence in situ hybridization, and reverse transcriptase polymerase chain reaction are necessary to clarify the various mechanisms leading to an MLL-AF10 fusion in acute myelocytic leukemia with 10;11 rearrangementMirjam Klaus, Susanne Schnittger, Torsten Haferlach, et al.
Seminars in Hematology|March 28, 2012
Controversies and open questions in the definitions and classification of the hypereosinophilic syndromes and eosinophilic leukemiasPeter Valent, Hans-Peter Horny, Bruce S Bochner, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|September 28, 2004
Four-fold staining including CD45 gating improves the sensitivity of multiparameter flow cytometric assessment of minimal residual disease in patients with acute myeloid leukemiaWolfgang Kern, Daniela Voskova, Susanne Schnittger, et al.
Pageof 60